RLAY vs WST · rev $3.4M vs P/E 35, rev $1.72B
Relay Therapeutics Inc (RLAY) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
RLAY currently screens at market cap $3.39B. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the RLAY and WST stock pages for the full models.
Not investment advice.